170 related articles for article (PubMed ID: 16006273)
1. Aspirin resistance: an evaluation of current evidence and measurement methods.
Martin CP; Talbert RL
Pharmacotherapy; 2005 Jul; 25(7):942-53. PubMed ID: 16006273
[TBL] [Abstract][Full Text] [Related]
2. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
3. Drug insight: aspirin resistance--fact or fashion?
Patrono C; Rocca B
Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
5. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
7. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
[TBL] [Abstract][Full Text] [Related]
8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
9. Can platelet function tests predict the clinical efficacy of aspirin?
Haubelt H; Anders C; Hellstern P
Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of the antiplatelet effect of aspirin.
Würtz M; Kristensen SD; Hvas AM; Grove EL
Curr Pharm Des; 2012; 18(33):5294-308. PubMed ID: 22724416
[TBL] [Abstract][Full Text] [Related]
11. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.
Mattiello T; Guerriero R; Lotti LV; Trifirò E; Felli MP; Barbarulo A; Pucci B; Gazzaniga P; Gaudio C; Frati L; Pulcinelli FM
J Am Coll Cardiol; 2011 Aug; 58(7):752-61. PubMed ID: 21816313
[TBL] [Abstract][Full Text] [Related]
12. Variability of response to antiplatelet therapy: what should we do next?
Shantsila E; Lip GY
Fundam Clin Pharmacol; 2009 Feb; 23(1):19-22. PubMed ID: 19267768
[No Abstract] [Full Text] [Related]
13. Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition.
Assadian A; Lax J; Meixner-Loicht U; Hagmüller GW; Bayer PM; Hübl W
J Vasc Surg; 2007 Jun; 45(6):1142-7; discussion 1147. PubMed ID: 17543677
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK; Walker LP; Halushka PV
Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
[TBL] [Abstract][Full Text] [Related]
15. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of aspirin resistance.
Floyd CN; Ferro A
Pharmacol Ther; 2014 Jan; 141(1):69-78. PubMed ID: 23993980
[TBL] [Abstract][Full Text] [Related]
19. A brief review on high on-aspirin residual platelet reactivity.
Pettersen AA; Arnesen H; Seljeflot I
Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and clopidogrel resistance.
Fitzgerald DJ; Maree A
Hematology Am Soc Hematol Educ Program; 2007; ():114-20. PubMed ID: 18024618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
